Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma

Andrew Ewens1, Enrico Mihich, M Jane Ehrke

  • 1Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

Anticancer Research
|November 30, 2005
PubMed
Abstract

Insights

The E0771 mouse breast cancer model spontaneously metastasizes to the lungs and peritoneal cavity. This model shows immunosuppression and is valuable for testing new breast cancer therapies.

Area of Science:

  • Oncology
  • Immunology
  • Animal Models

Background:

  • Effective breast cancer treatment is limited for metastatic disease.
  • Early intervention is crucial for successful breast cancer therapy.
  • A need exists for a reliable mouse model of breast cancer metastasis.

Purpose of the Study:

  • To evaluate the E0771 medullary adenocarcinoma as a model for metastatic breast cancer.
  • To characterize the metastatic potential and associated pathologies of the E0771 model in C57BL/6 mice.

Main Methods:

  • Subcutaneous implantation of E0771 cells in syngeneic C57BL/6 mice.
  • Utilized standard pathological, histological, and immunological techniques for analysis.

Main Results:

  • E0771 tumors exhibited aggressive local invasion (56%) and spontaneous lung metastasis (52%).
  • Significant immunosuppression was observed, indicated by suppressed immune cell activity.
  • Tumor progression led to bloody ascites (56%) and shock (72%) due to peritoneal invasion.

Conclusions:

  • The E0771 model effectively mimics human metastatic breast cancer.
  • This model is suitable for preclinical testing of novel breast cancer treatments.
  • The E0771 model aids in studying the mechanisms of breast cancer metastasis.